| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |